Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 3036-3042

  Frazier Jessen, M R ^a   Mott, F J ^a   Witte, P L ^a   Kovacs, E J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TALC;

ABDOMEN; ADHESION; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CHEMISTRY; CONNECTIVE TISSUE; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; MACROPHAGE; MOUSE; ORGAN SIZE; OVARIECTOMY; PATHOLOGY; PERITONEAL DISEASE;

ABDOMEN; ADHESIONS; ANIMALS; CHEMOKINE CCL2; CONNECTIVE TISSUE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; MICE; MICE, INBRED C57BL; ORGAN SIZE; OVARIECTOMY; PERITONEAL DISEASES; RNA, MESSENGER; TALC;

EID: 0030584710     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Ansar-Ahmed, S., W. J Penhale, and N. Talal. 1985 Sex hormones, immune responses and autoimmune disease. Am J. Pathol 121:531.
2. Grossman, C. J. 1985. Interactions between the gonadal steroids and the immune system. Science 227.257.
3. Schuurs, A H. W. M., and H. A. M. Verhuel 1990 Effects of gender and sex steroids on the immune response. J. Steroid Biochem. 35:157.
4. Holmdahl, R., and L Jansson. 1988. Estrogen-mduced suppression of collagen arthritis III Adult thymectomy does not affect the course of arthritis or the estrogen-mediated suppression of T-cell immunity. Brain Behav Immun. 2.123.
5. Czirjak, L., A. Bokk, G. Csontos, G. Oorincz, and G. Szegedi. 1989. Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm. Venereol. 69:533.
6. Inman, R. D. 1978 Immunological sex differences and the female predominance of systemic Iupus erythematosus. Arthritis Rheum. 21:849
7. Steen, V D., and T. A. Medsger. 1990. Epidemiology and natural history of systemic sclerosis. Rheum. Dis Clin North Am. 16:1
8. Christiansen, C. 1993 Prevention and treatment of osteoporosis with hormone replacemeat therapy, Int J. Fertil. Menopausal Studies 38:45.
9. Knopp, R. H. 1988. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet. Gynecol 72:23S
10. Weusten, J. J., M. A. Blankenstein, F. H. Gmelig-Meyling, H. I. Scuurman, L Kater, and J H Thijssen 1986. Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol 112:409
11. Cocchiara, R , G. Albeggiani, G Di Trapani, A. Azzolina, N. Lampiasi, F. Rizzo, and D Geraci. 1990. Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens Int. Arch. Allergy Allergy. Immunol 93:192.
12. Gulshan, S , A. B. McCruden, and W. H Stimson. 1990. Oestrogen receptors in macrophages. Scand J Immunol. 31:691.
13. Krebs, H. B., and D. R. Goplerud. 1987. Mechanical intestinal obstruction in patients with gynecologic disease: a review of 368 patients Am J. Obstet. Gynecol 157.577
14. Haney, A. F. 1993. Endometriosis, macrophages, and adhesions. In Gynecologic Surgery and Adhesion Prevention. M. P. Diamond, G. S. diZerega, C B Linsky, and R. L. Reid, eds. Wiley-Liss, Inc., New York. p. 19
15. Kovacs, E. J 1991. Fibrogenic cytokines: the role of immune mediators in the development of fibrosis. Immunol. Today 12:17.
16. Kovacs, E. J., and L. A. DiPietro. 1994. Fibrogenic cytokines and connective tissue production FASEB J. 8:854.
17. Cutroneo, K. R., K. M Sterling, Jr., and S. Schull. 1986. Regulation of matrix accumulation. In Biology of the Extracellular Matrix. R. P. Mecham, ed. Academic Press, Orlando, p. 119
18. Cockayne, D., K. M. Sterling, Jr., S. Shull, K. P. Mintz, S. Illeyne, and K. R. Cutroneo 1986. Glucocorticoids decrease the synthesis of type I procollagen mRNAs. Biochemistry 25:3202.
19. Walsh, M. J., N, S Leleiko, and K. M. Sterling, Jr. 1987. Regulation of types I, III, and IV procollagen mRNA synthesis in glucocorticoid mediated intestinal development. J. Biol. Chem. 262:10814.
20. Beutler, B., N. Krochin, I. W. Milsark, C. Leudke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxia resistance. Science 232:977.
21. Kawahara, R. S., Z.-W. Deng, and T. F. Deuel. 1991. Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J. Biol. Chem. 266.13261.
22. Lee, S. W , A P Tsou, H. Chan, J Thomas, K Petrie, E. M. Eugui, and A. C. Allison 1988. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc. Natl. Acad. Sci. USA 85:1204
23. Mukaida, N., C. C. O. Zachariae, O. L. Gusella, and K Matsushima. 1991 Dcxamethasone inhibits the induction of monocyte chemotactic-activating factor production by interleukin-1 or tumor necrosis factor. J. Immunol. 146:1212.
24. Staruch, M. J., and D. D. Wood. 1985. Reduction of serum interleukin-1-like activity after treatment with dexamethasone J. Leukocyte Biol. 37:193.
25. Waage, A., G. Slupphaug, and R. Shalaby 1990. Glucocorticoids inhibit the production of IL-6 from monocytes, endothehal cells and fibroblasts. Eur. J Immunol. 20:2439.
26. Styrt, B., and B. Sugarman. 1991. Estrogen and infection. Rev. Infect. Dis 13: 1139.
27. Frazier-Jessen, M. R., and E. J. Kovacs. 1993. Abdominal wall thickness as a means of assessing peritoneal fibrosis in mice. J. Immunol Methods 162:115.
28. Langdon, S. P., A. Ritchie, K. Young, A. J Crew, V. Sweeting, T. Bramley, S. Hiller, R. A. Hawkins, A L Tesdale, and W. R. Miller. 1993. Contrasting effects of 17β estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo. Int. J. Cancer 55:459.
29. Bain, S. D., E. Jensen, D. L. Celino, M. C. Bailey, M M. Lantry, and M. W. Edwards 1993. High-dose gestagens modulate bone resorption and enhance estrogen induced endosteal bone formation in the ovariectomized mouse. J. Bone Miner. Res. 8-219.
30. Ellis, H., W. Harrison, and T. B. Hugh. 1965. The healing of peritoneum under normal and pathological conditions. Br. J. Surg. 52:471.
31. Hubbard, T B., M. Z. Khan, V. R. Carag, V. E. Albites, and G. M. Hricko. 1967. The pathology of peritoneal repair its relation to the formation of adhesions. Ann. Surg. 165:908.
32. Radzioch, D., B. Bottazzi, and L. Varesio 1987. Augmentation of c-fos mRNA expression by activators of protein kinase C in fresh, terminally differentiated resting macrophages Mol. Cell Biol 7:595.
33. Frazier-Jessen, M. R , and E. J Kovacs. 1995. Estrogen regulation of JE/MCP-1 mRNA expression in macrophages J Immunol. 154:1838
34. Fuhlbrigge, R. C., D. D. Chaplin, J. M. Kiely, and E. R. Unanue. 1987. Regulation of interieukin-1 gene expression by adherence and lipopolysaccharides. J. Immunol. 138:3799
35. Kovacs, E J., J. J Oppenheim, and H. A. Young. 1986. Induction of c-fos and c-myc expression in T lymphocytes after treatment with recombinant interleukin 1-α. J. Immunol. 137:3649
36. Butterstein, G. M., D. A. Damassa, and C. H. Sawyer. 1980. The use of polyethylene estrogen capsules in the chronic steroid treatment of prepubertal female rats (40774). Proc. Soc. Exp. Biol. Med 163:340.
37. Gee, D. M., K. Flurkey, C. V. Mobbs, Y. N. Sinha, and C. E. Finch. 1984 The regulation of luteinizing hormone and prolactin in C57BL/6J mice: effects of estradiol implant size, duration of ovariectomy, and aging Endocrinology 114: 685
38. Mobbs, C. V., D Cheyney, Y. N. Sinha, and C. E Finch. 1985. Age-correlated and ovary-dependent changes in relationships between plasma estradiol and luteinizing hormone, prolactin, and growth hormone in female C57BL/6J mice. Endocrinology 116:813.
39. Jesionowska, H., K. Karelus, and J. F. Nelson 1990 Effects of chronic exposure to estradiol on ovarian cyclicity in C57BL/6J mice: potentiation at low doses and only partial suppression at high doses Biol. Reprod. 43:312.
40. De, M., and G. W. Wood 1990. Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus. J. Endocrinol. 126:417
41. Bergman, M. D., B. S. Schachter, K. Karelus, E. P. Combatsiaris, T. Garcia, and J F. Nelson. 1992. Up-regulation of the uterine estrogen receptor and its messenger nbonucleic acid during the mouse estrous cycle: the role of estradiol. Endocrinology 130:1923.
42. Leibovich, S J., and R Ross. 1975. The role of the macrophage in wound repair: a study with hydrocortisone and anti-macrophage serum. Am. J. Pathol. 78:71.
43. 1 by eosinophils during cutaneous wound healing in the hamster. Am. J Pathol. 143:130.
44. DiPietro, L. A., S. M. Rabbe, P. J. Polvarini, and E. J. Kovacs. 1995. Expression of JE/MCP-1 in dermal wound repair. Am. J. Pathol. 146:868.
45. Roth, G. S., S. M. Harman, and S. I. Lamberg. 1981. Altered ovarian regulation of wound healing during aging. Proc. Soc. Exp. Biol. Med. 166:17
46. Dyson, M., and J Joseph. 1971. The effect of female sex hormones on tissue regeneration in the rabbit's ear J. Endocrinol 51:685.
47. Pacifici, R., L. Rifas, R. McCracken, and L. V. Avioli. 1990. The role of interleukin-1 in postmenopausal bone loss. Exp. Gerontol. 25:309.
48. Ralston, S. H., R. G Russell, and M. Gowen. 1990. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cell in postmenopausal women. J. Bone Miner Res. 5:983.
49. Golan, A., O. Stolik, S. Wexler, D. Niv, A. Ber, and M. P. David 1991. The effect of amniotic fluid on intraperitoneal adhesion formation, an experimental study. Int. J. Fertil. 36:317.
50. Hench, P. S. 1938. The ameliorating effect of pregnancy on chronic atropic infections, rheumatoid arthritis, fibrosititis and intermittent hydrarthrosis. Mayo Clin. Proc. 13:161.
51. Vandenbroncke, J. P, J. C. M. Witteman, H. A. Valkenburg, J. W. Boersma, A. Cats, J. J. M. Festen, A. P. Hartman, O. Huber-Bruning, J J. Rasker, and J. Weber. 1986. Non-contraceptive hormones and rheumatoid arthritis in premenopausal and postmenopausal women. Arthritis Rheum. 255:1299.
52. Carr, R B. 1990. The fetal maternal placental unit. In Principles and Practice of Endocrinology and Metabolism. K. L. Becker, ed. JB Lippincott, Philadelphia, p 788
53. Koch, A. E., S. L Kunkel, W. H. Pierce, M. R. Shah, D. Parikh, H. L. Evanoff, G. K Haines, M. D. Burdick, and R. M. Strieter. 1993. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am. J Pathol. 142:1423.
54. Nelken, N. A., S. R. Coughlin, D. Gordon, and J. N. Wilcox. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin, Invest. 88: 1121.
55. Takeya, M., T. Yoshimura, E. J. Leonard, and K. Takahashi. 1993 Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an antimonocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 24:534.
56. Yu, X., S. Dluz, D. T. Graves, L. Zhang, H N. Antoniades, W. Hollander, S Prusty, A. J. Valente, C. J. Schwartz, and G. E. Sonenshein. 1992. Elevated expression of monocyte chemoattractant protein-1 by vascular smooth muscle cells in hypercholesterolemic primates Proc. Natl. Acad Sci. USA 89:6953.
57. Flory, C. M., M. L. Jones, and J. S. Warren 1993 Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein-2. Lab. Invest. 69:396.
58. Brieland, J. K., M. L. Jones, C. M. Flory, G R. Miller, J. S Warren, S. H. Phan, and J. C. Fantone. 1993. Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury. Am. J Respir Cell Mol. Biol. 9:300.
59. Kovacs, E. J., B. Brock, I. Silber, and J. E. Neuman. 1993. Production of fibrogenic cytokines by interleukin-2-treated peripheral blood leukocytes: expression of transforming growth factor β and platelet-derived growth factor β chain genes. Obstet. Gynecol. 83:29.
60. Ponec, M., C. de Haas, B. N. Bachra, and M. K Polano. 1977. Effects of glucocorticoids on primary human skin fibroblasts. I. Inhibition of the proliferation of cultured primary human skin and mouse L929 fibroblasts. Arch. Dermutol Res. 259:117.
61. Saarni, H., and M. Tammi. 1978. Time and concentration dependence of the action of cortisol on fibroblasts in vitro. Biochim. Biophys Acta 540:217.
62. Sato, F., Y. Ouchi, A. Masuyama, T. Nakamura, T. Hosio, Y. Okamato, N. Sasaki, and H. Orimo. 1993. Effects of estrogen replacement on insulin-like growth factor concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophrectomized rats. Calcif. Tissue Int. 53: 111.
63. Polan, M. L., J. Loukides, P. Nelson, S. Carding, M. Diamond, A. Walsh, and K Bottomly, 1989. Progesterone and estradiol modulate interleukin-1β messenger ribonucleic acid levels in cultured human peripheral monocytes J. Clin Endocrinol. Metab. 89:1200
64. Kovacs, E. J., D S. Ramer-Quinn, D. E. Faunce, F. J. Mott, P.-W. W. Dy, and M. R. Frazier-Jessen. 1996. Estrogen regulation of JE/MCP-1 mRNA expression in murine fibroblasts. J. Leukocyte Biol. In press.
65. Malet, C., A. Gompel, H. Yaneva, H. Cren, N. Fidji, I. Mowszowicz, F. Kuttenn, and P. Mauvais-Jarvis. 1991. Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts' immunocytochemical studies. J. Clin. Endocrinol. Metab. 73:8.
66. Kato, S., L. Toro, J. Yamauchi, S. Masushigi. M. Bellard, and P. Chambon. 1992. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68:731.
67. Freter, R. R., J.-C. Irminger, J. A. Porter, S. D. Jones, and C. D. Sules. 1992. A novel 7-nucleotide motif located in 3' untranslated sequences of immediate early gene set mediates platelet-derived growth factor induction of the JE gene. Mol. Cell. Biol. 12:5288
68. Aronica, S. M., W. L. Kraus, and B. S. Katzenellenbogen. 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-reguiated gene transcription. Proc. Natl Acad. Sci USA 91:8517
69. Webb, P., G. N. Lopez, R. M. Uht, and P. J. Kushner 1995. Tamoxifen activation of the estrogen receptor pathway/AP-1 pathway: potential origin for the cellspecific estrogen-like effects of anti-estrogens Mol. Endocrinol. 9:443.
70. Timmers, H. T. M., G. J. Pronk, J. L. Bos, and A. J. van Eb. 1990. Analysis of the rat JE promotor identifies an AP-1 binding site essential for basal expression but not for TPA induction. Nucleic Acids Res. 18:23.